Monoclonal For Gram-Negative Sepsis
HA-1A (Centoxin - Centocor), a monoclonal IgM antibody against endotoxin from gram-negative bacteria, may soon be approved for marketing by the US Food and Drug Administration. Commercially available in Europe, HA-1A has been used in the USA as an investigational drug. E5 (Xomen - Xoma), another monoclonal IgM antibody against endotoxin, is also available here for investigational use....
Cannot Access - We are sorry, but you cannot access the requested article.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
Information about the article:
Title: Monoclonal For Gram-Negative Sepsis
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 856
Article Code: 856a
Date: November 1, 1991
Volume: 33
Pages: 103-104
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 856
Article Code: 856a
Date: November 1, 1991
Volume: 33
Pages: 103-104
Subscribe to The Medical Letter on Drugs and Therapeutics for instant access to this article. Add this downloadable, electronic article to your cart (U.S. English version only)